BD Committed To Global Health; Mitigating Blood Culture Vial Supplier Issue With FDA Collaboration, Rapid Production, And Restarting Glass Vial Production; Manual Allocation To Prioritize Clinical Needs; No Material Financial Impact Expected
BD致力于全球医疗健康；通过与FDA合作，加快生产并重新开始玻璃瓶生产来解决血液培养瓶供应商问题；手动分配来优先考虑临床需求；预计不会对财务产生实质性影响。